Ritanserin inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT2 receptor, adrenergic α1, adrenergic α2, D2 receptor, and H1 receptor.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
